| Glioma epigenetics: from subclassification to novel treatment options O Gusyatiner, ME Hegi Seminars in cancer biology 51, 50-58, 2018 | 448 | 2018 |
| Autophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescence C Lenain, O Gusyatiner, S Douma, B van den Broek, DS Peeper Carcinogenesis 36 (11), 1263-1274, 2015 | 64 | 2015 |
| BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma O Gusyatiner, P Bady, MDT Pham, Y Lei, J Park, RT Daniel, M Delorenzi, ... Neuro-oncology 23 (10), 1680-1692, 2021 | 23 | 2021 |
| Hyperpolarized 13C-glucose magnetic resonance highlights reduced aerobic glycolysis in vivo in infiltrative glioblastoma M Mishkovsky, O Gusyatiner, B Lanz, C Cudalbu, I Vassallo, MF Hamou, ... Scientific Reports 11 (1), 5771, 2021 | 15 | 2021 |
| Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice C Cudalbu, P Bady, M Lai, L Xin, O Gusyatiner, MF Hamou, M Lepore, ... Acta Neuropathologica Communications 9, 1-16, 2021 | 9 | 2021 |
| BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression A Tancredi, O Gusyatiner, P Bady, MC Buri, R Lomazzi, D Chiesi, ... Cell Death & Disease 13 (12), 1037, 2022 | 7 | 2022 |
| Evolution patterns of glioblastoma from single-cell whole-genome sequencings H Choi, WJ Cho, O Gusyatiner, P Bady, M Bueno, R Daniel, K Harshman, ... Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| OTME-13. Integration of metabolic and transcriptional signatures of glioblastoma invasion reveals extracellular matrix reorganization and vasculature remodeling C Cudalbu, P Bady, M Lai, L Xin, O Gusyatiner, MF Hamou, M Lepore, ... Neuro-oncology Advances 3 (Suppl 2), ii16, 2021 | | 2021 |
| CBMT-15. METABOLIC AND TRANSCRIPTIONAL PROFILES OF GBM INVASION: COMPARISON OF PATIENTS AND PAIRED PATIENT DERIVED XENOGRAFTS USING1H MAGNETIC RESONANCE SPECTROSCOPY AND … M Hegi, C Cudalbu, P Bady, M Lai, L Xin, O Gusyatiner, MF Hamou, ... Neuro-Oncology 20 (suppl_6), vi35-vi35, 2018 | | 2018 |
| BET inhibitors synergize with HDAC inhibitors and downregulate expression of interferon response genes in glioblastoma O Gusyatiner, MDT Pham, Y Lei, J Park, P Bady, M Delorenzi, M Hegi Cancer Research 78 (13_Supplement), 2923-2923, 2018 | | 2018 |
| Epigenetic therapy a good BET for glioblastoma? A systems biology approach to identify a rational combination therapy. O Gusyatiner Université de Lausanne, Faculté de biologie et médecine, 2018 | | 2018 |
| Dynamics and role of genome-nuclear lamina interactions in oncogene-induced senescence O Gusyatiner O. Gusyatiner, 2013 | | 2013 |
| Lactate production but not pool-size is altered in infiltrative mouse model of human GBM: a 1H MRS and hyperpolarized [2H7, 13C6] D-glucose study M Mishkovsky, O Gusyatiner, B Lanz, I Vassallo, MF Hamou, R Gruetter, ... | | |
| Hyperpolarized 13 C-glucose MRS: a potential biosensor to visualize the infiltrative front in GBM M Mishkovsky, O Gusyatiner, B Lanz, C Cudalbu, I Vassallo, MF Hamou, ... | | |
Monika HegiFull Professor, Lausanne University Hospital, SwitzerlandVerified email at chuv.ch
